Dinnertime Carbs Reduce Diabetes And Cardiovascular Risk

Dinnertime Carbs Reduce Diabetes And Cardiovascular Risk

According to new research by the Hebrew University of Jerusalem, limiting carbs to dinnertime can help those who are suffering from severe or morbid obesity, reducing the risk for diabetes and cardiovascular risk.
By opting for this diet, a secretion pattern of hormones that are responsible for both satiety and hunger and hormones that are associated with metabolic syndrome are influenced. It can help to prevent diabetes and cardiovascular disease from ever occurring.
A research student name Sigal Sofer who was under the auspices of Professor Zecharia Madar at the Institute of Biochemistry, Food Science and Nutrition at the Hebrew University’s Robert H. Smith Faculty of Agriculture, Food and Environment carried out the research of this diet.

Apple Peels, Diabetes and Muscle Wasting

Apple Peels, Diabetes and Muscle Wasting: You might not want to peel that apple before eating it, let alone put an apple peel down the garbage disposal or in the trash container under the sink.
Apple peels contains a good dose of ursolic acid. Ursolic acid is a natural compound found in apple peels called pentcyclic triterpenoid and helps to burn fat and build muscle. In a recent study in which mice were used, apple peel was shown to lower blood sugar levels, cholesterol and triglycerides. Ursolic acid is also known as malol, prunol, urson, 3-B-hydroxy-urs-12-en-28-oic acid.
This study was conducted by Dr. Chris Adams, an endocrinologist and senior author of the study for the University of Iowa. The study showed that the ursolic acid found in apple peels could be helpful with the wasting away of muscles that occurs in certain diseases, and also possibly help with metabolic disorders like diabetes. The study results were published in the June 2011 issue of Cell Metabolism.

From the information from his study, Dr. Adams stated, “We found that it actually promoted the growth of muscle, so the mice got bigger muscles and actually got stronger. We can measure mouse strength with a little machine called a grip strength meter.” He added, “It didn’t have any harmful effect on the kidneys or liver or anything like that which makes sense because it’s a natural compound that we actually eat.”
The mice that received the ursolic acid became leaner and had lower blood sugar levels, cholesterol and triglycerides. Further testing will be needed before it is determined that the same positive results will prove to be true for humans.
The muscle-building aspect of the ursolic acid would be beneficial in the treatment of the infirmed and elderly.
Also, it is not known whether the amount of ursolic acid that is consumed on a daily basis by humans would produce the same results.
Ursolic acid is found in apple peels, but it is also found in other plants, including bilberries, cranberries, hawthorn, prunes, elder flowers, lavender, oregano, thyme and peppermint. Ursolic acid has already been recognized as an inhibitor of various types of cancer cells.
Ursolic acid is currently used by the cosmetic industry in the manufacture of cosmetics in its topical form due to its anti-tumor (skin cancer) properties.
Type 1 and Type 2 diabetes diagnoses are growing in number each year. Every little piece of new information garnered that could help in the treatment of these conditions helps all those with these numerous conditions.
In the meantime, we might want to do what we are always told: Eat your fruits and veggies.

New Grant Issued To Find Out Why Diabetes Accelerates Alzheimer’s

Past studies have shown that if you have diabetes, you are more likely to be diagnosed with Alzheimer’s disease when you get older, and having diabetes even accelerates the Alzheimer’s progression.

Why?  The complete answer is unknown at this time, although many theories have been culled from many different studies.
Professor Miranda Reed, Assistant Professor in Behavioral Neuroscience at the West Virginia University Department of Psychology, hopes to take a step in finding the answer to this question, as well as in helping to find the best treatment of the two conditions.   Funded by the Alzheimer’s Association, with a grant of $97,000.00 for research, Dr. Reed will attempt to find the answer to “why” having diabetes increases the odds of developing Alzheimer’s disease.  When that answer is finally answered only then can steps be taken to create a medication(s) for these two different diseases at the same time.
Dr. Reed is creating a mouse model that has both diabetes and Alzheimer’s disease.  At this time, it is unknown whether the medication for Alzheimer’s has the same effect on a person with just Alzheimer’s as it does on those who have Alzheimer’s and another disease.  This mouse will help Dr. Reed in understanding the neurological progression of both diabetes and Alzheimer’s.  In this study, the behavior of the mouse, the brain functions and treatments will be conducted in a controlled environment.  From the data collected, she will be able to tell the experiences of mice to humans so that there is a more clear understanding between diabetes and Alzheimer’s.  Dr. Reed hopes to answer some of the questions that are now revolving around the current treatment for Alzheimer’s in conjunction with the current treatment of diabetes.
As people get older, their likelihood of developing diabetes increases.  Also with age, their likelihood of developing Alzheimer’s increases.  According to Dr. Reed, most people who have Alzheimer’s disease also have an additional disease, and in many cases this additional disease is diabetes.  Dr. Reed will focus on the treatment of and the management of these two diseases together.
Currently, it is an unknown as to whether or not the medications used for the treatment of Alzheimer’s works in the same manner on a person suffering with just Alzheimer’s as it does on a person with both Alzheimer’s and diabetes.  Dr. Reed’s study might provide answers as to how the different medications for one disease might affect the other disease that a patient has.  This new information could lead to a better understanding of drugs that need to be created and eventually distributed to and used by the general public.
Assisting in Dr. Reed’s study will be two graduate students, Holly Hunsberger and Carolyn Rudy, who are at the Behavioral Neuroscience Program at the university.